UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 68 filers reported holding UROGEN PHARMA LTD in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $140,899 | +1.9% | 10,057 | -24.7% | 0.00% | – |
| Q2 2023 | $138,224 | -82.4% | 13,355 | -84.3% | 0.00% | – |
| Q1 2023 | $784,199 | -43.3% | 84,870 | +18.3% | 0.00% | – |
| Q3 2020 | $1,383,000 | -26.9% | 71,738 | -0.9% | 0.00% | – |
| Q2 2020 | $1,891,000 | +632.9% | 72,366 | +400.1% | 0.00% | – |
| Q1 2020 | $258,000 | -75.6% | 14,469 | -54.4% | 0.00% | -100.0% |
| Q4 2019 | $1,058,000 | +366.1% | 31,719 | +595.1% | 0.00% | 0.0% |
| Q2 2018 | $227,000 | – | 4,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,111,050 | $9,099,000 | 4.23% |
| GREAT POINT PARTNERS LLC | 873,424 | $7,153,000 | 1.72% |
| Wildcat Capital Management, LLC | 533,139 | $4,366,000 | 1.45% |
| Opaleye Management Inc. | 238,670 | $1,955,000 | 0.88% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,949,489 | $24,156,000 | 0.44% |
| Annandale Capital, LLC | 84,331 | $691,000 | 0.27% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $206,000 | 0.18% |
| RTW INVESTMENTS, LP | 857,464 | $7,023,000 | 0.18% |
| Harel Insurance Investments & Financial Services Ltd. | 1,025,611 | $8,400,000 | 0.18% |
| BENDER ROBERT & ASSOCIATES | 41,131 | $337,000 | 0.13% |